152 related articles for article (PubMed ID: 33560095)
1. Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients.
Taber DJ; Hirsch J; Keys A; Su Z; McGillicuddy JW
Ther Drug Monit; 2021 Jun; 43(3):401-407. PubMed ID: 33560095
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus Intrapatient Variability on Graft Outcomes in Adherent Renal Transplantation Patients: A Cross-Sectional Study.
Nafar M; Keshtkari S; Ziaie S; Firouzan A; Borumandnia N; Dalili N; Poorrezagholi F; Samadian F; Samavat S
Iran J Kidney Dis; 2024 May; 18(3):187-194. PubMed ID: 38904339
[TBL] [Abstract][Full Text] [Related]
3. No Apparent Influence of Nonadherence on Tacrolimus Intrapatient Variability in Stable Kidney Transplant Recipients.
Gokoel SRM; Zwart TC; Moes DJAR; van der Boog PJM; de Fijter JW
Ther Drug Monit; 2020 Oct; 42(5):702-709. PubMed ID: 32941396
[TBL] [Abstract][Full Text] [Related]
4. Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation.
Park Y; Lee H; Eum SH; Kim HD; Ko EJ; Yang CW; Chung BH
Front Immunol; 2021; 12():746013. PubMed ID: 34659243
[TBL] [Abstract][Full Text] [Related]
5. Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome.
Kuypers DRJ
Clin Pharmacol Ther; 2020 Feb; 107(2):347-358. PubMed ID: 31449663
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation.
Xie W; Fan S; Liu R; Yan W; Su C; Zheng K; Wang X; Wang Z
Transplant Rev (Orlando); 2024 Jul; 38(3):100842. PubMed ID: 38537484
[TBL] [Abstract][Full Text] [Related]
7. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
Shuker N; Cadogan M; van Gelder T; Roodnat JI; Kho MM; Weimar W; Hesselink DA
Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255
[TBL] [Abstract][Full Text] [Related]
8. High Intrapatient Variability in Tacrolimus Exposure Calculated Over a Long Period Is Associated With De Novo Donor-Specific Antibody Development and/or Late Rejection in Thai Kidney Transplant Patients Receiving Concomitant CYP3A4/5 Inhibitors.
Larpparisuth N; Pongnatcha T; Panprom P; Promraj R; Premasathian N; Vongwiwatana A
Ther Drug Monit; 2021 Oct; 43(5):624-629. PubMed ID: 33278239
[TBL] [Abstract][Full Text] [Related]
9. Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients.
Abu Bakar K; Mohamad NA; Hodi Z; McCulloch T; Williams A; Christian M; Key T; Kim JJ
Pediatr Nephrol; 2019 Dec; 34(12):2557-2562. PubMed ID: 31520127
[TBL] [Abstract][Full Text] [Related]
10. High Tacrolimus Intrapatient Variability and Subtherapeutic Immunosuppression are Associated With Adverse Kidney Transplant Outcomes.
Mendoza Rojas A; Hesselink DA; van Besouw NM; Dieterich M; de Kuiper R; Baan CC; van Gelder T
Ther Drug Monit; 2022 Jun; 44(3):369-376. PubMed ID: 35394988
[TBL] [Abstract][Full Text] [Related]
11. High intra-patient variability of tacrolimus within post-operative 1 month predicted worse 1-year outcomes in pediatric liver transplant recipients.
Chen F; Yong JK; Shen C; Zhou T; Feng M; Wan P; Luo Y; Lin H; Qian Y; Xia Q
Eur J Clin Pharmacol; 2024 Jul; 80(7):1017-1027. PubMed ID: 38502358
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation.
Gonzales HM; McGillicuddy JW; Rohan V; Chandler JL; Nadig SN; Dubay DA; Taber DJ
Am J Transplant; 2020 Aug; 20(8):1969-1983. PubMed ID: 32406604
[TBL] [Abstract][Full Text] [Related]
13. Effects of tacrolimus intrapatient variability and CYP3A5 polymorphism on the outcomes of pediatric kidney transplantation.
Choi JS; Ko H; Kim HK; Chung C; Han A; Min SK; Ha J; Kang HG; Ha IS; Min S
Pediatr Transplant; 2022 Sep; 26(6):e14297. PubMed ID: 35466485
[TBL] [Abstract][Full Text] [Related]
14. Combined Effect of Inter- and Intrapatient Variability in Tacrolimus Exposure on Graft Impairment Within a 3-Year Period Following Kidney Transplantation: A Single-Center Experience.
Stefanović NZ; Veličković-Radovanović RM; Danković KS; Mitić BP; Paunović GJ; Cvetković MB; Cvetković TP
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):749-760. PubMed ID: 32886348
[TBL] [Abstract][Full Text] [Related]
15. Impact of converting adult kidney transplant recipients with high tacrolimus variability from twice daily immediate release tacrolimus to once daily LCP-Tacrolimus.
Taber DJ; Bartlett F; Patel N; Sprague T; Patel S; Newman J; Andrade E; Rao N; Salas MAP; Casey M; Dubay D; Rohan V
Clin Transplant; 2023 May; 37(5):e14941. PubMed ID: 36809653
[TBL] [Abstract][Full Text] [Related]
16. Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial.
Fleming JN; Gebregziabher M; Posadas A; Su Z; McGillicuddy JW; Taber DJ
Am J Health Syst Pharm; 2021 Jul; 78(14):1287-1293. PubMed ID: 33821958
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus intrapatient variability in BK virus nephropathy and chronic calcineurin toxicity in kidney transplantation.
Turgut D; Sayin B; Soy EA; Topcu Dİ; Ozdemir BH; Haberal M
Saudi J Kidney Dis Transpl; 2021; 32(2):348-354. PubMed ID: 35017328
[TBL] [Abstract][Full Text] [Related]
18. Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort study.
Hiramitsu T; Tomosugi T; Futamura K; Okada M; Nishihira M; Goto N; Ichimori T; Narumi S; Kobayashi T; Uchida K; Watarai Y
Int Immunopharmacol; 2021 Feb; 91():107038. PubMed ID: 33388731
[TBL] [Abstract][Full Text] [Related]
19. Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients.
Cooper M; Dunne I; Kuten S; Curtis A; Graviss EA; Nguyen DT; Hobeika M; Gaber AO
Transplant Proc; 2021 Apr; 53(3):984-988. PubMed ID: 33246588
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.
Sablik KA; Clahsen-van Groningen MC; Hesselink DA; van Gelder T; Betjes MGH
PLoS One; 2018; 13(5):e0196552. PubMed ID: 29746495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
